← All diseases
Muscles and connective tissue
Severe myasthenia gravis
Would you like to receive a message when there is new research on Severe myasthenia gravis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll see one sentence explaining what was researched — and you'll be notified as soon as there is new research on Severe myasthenia gravis. View what Premium costs.
Publications and studies (1470)
- Incidence and causes of overdiagnosis of myasthenia gravis. (2023/06/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Thymic carcinoma with myasthenia gravis: A case report. (2023/06/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. The short and long-term effects of open vs minimally invasive thymectomy in myasthenia gravis patients: a systematic review and meta-analysis. (2023/05/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Comorbidities in Patients with Vitiligo: A Systematic Review and Meta-Analysis. (2023/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Serological diagnosis of myasthenia gravis and its clinical significance. (2023/04/15) ♡
- Post-Operative Outcomes Associated With Open Versus Robotic Thymectomy: A Propensity Matched Analysis. (2023/04/01) ♡
- Characterization of Immune Checkpoint Inhibitor-Induced Myasthenia Gravis Using the US Food and Drug Administration Adverse Event Reporting System. (2023/04/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Dynamic nomogram for predicting generalized conversion in adult-onset ocular myasthenia gravis. (2023/04/01) ♡
- Seasonal Variation in Neurologic Hospitalizations in the United States. (2023/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Role of Human Microbiota in Myasthenia Gravis: A Narrative Review. (2023/03/10) ♡
- Complement biomarkers reflect the pathological status of neuromyelitis optica spectrum disorders. (2023/03/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Complement Inhibition in Myasthenia Gravis and Neuromyelitis Optica Spectrum Disorder. (2023/03/01) ♡
- Human Parvovirus B19 May Be a Risk Factor in Myasthenia Gravis with Thymoma. (2023/03/01) ♡
- SOX1 antibody-related paraneoplastic neurological syndromes: clinical correlates and assessment of laboratory diagnostic techniques. (2023/03/01) ♡
- Proteolytic ectodomain shedding of muscle-specific tyrosine kinase in myasthenia gravis. (2023/03/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. ASO Author Reflections: A Possible New Etiology of Thymoma-Associated Myasthenia Gravis-Human Parvovirus B19. (2023/03/01) ♡
- Costs and Utilization of New-to-Market Neurologic Medications. (2023/02/28) ♡
- A real-world analysis of factors associated with high healthcare resource utilization and costs in patients with myasthenia gravis receiving second-line treatment. (2023/02/15) ♡
- Investigation of the Underlying Mechanism of Huangqi-Dangshen for Myasthenia Gravis Treatment via Molecular Docking and Network Pharmacology. (2023/02/08) ♡
- A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens. (2023/02/01) ♡
- Autologous hematopoietic stem cell transplant for the treatment of refractory myasthenia gravis with anti-muscle specific kinase antibodies. (2023/02/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Increased risk of Lambert-Eaton myasthenic syndrome (LEMS) in small-cell lung cancer patients treated with immune checkpoint inhibitor. (2023/02/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. COVID19 vaccine in myasthenia gravis patients: safety and possible predictors of disease exacerbation. (2023/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A very late onset AChR and MuSK double positive myasthenia gravis: a case description and literature review. (2023/02/01) ♡
- Novel slow-binding reversible acetylcholinesterase inhibitors based on uracil moieties for possible treatment of myasthenia gravis and protection from organophosphate poisoning. (2023/01/15) ♡
- Reduced quality of life in myasthenia gravis patients: A study on 185 patients from China. (2023/01/12) ♡
- Serum neurofilament light chain in myasthenia gravis subgroups: An exploratory cohort and case-Control study. (2023/01/11) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Exploring the role of immune checkpoint inhibitors in the etiology of myasthenia gravis and Lambert-Eaton myasthenic syndrome: A systematic review. (2023/01/09) ♡
- Traditional Chinese medicine improves myasthenia gravis by regulating the symbiotic homeostasis of the intestinal microbiota and host. (2023/01/06) ♡
- Clinical characteristics of myasthenia gravis (MG) patients developing other autoimmune diseases after thymectomy from one single center cohort. (2023/01/01) ♡
- The systemic inflammation markers as possible indices for predicting respiratory failure and outcome in patients with myasthenia gravis. (2023/01/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Vitamin D and myasthenia gravis. (2023/01/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Myasthenia gravis and thyroid cancer. (2023/01/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Prevalence of depression and anxiety among myasthenia gravis (MG) patients: A systematic review and meta-analysis. (2023/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Myocarditis-myositis-myasthenia gravis overlap syndrome depending on immune checkpoint inhibitor. (2023/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Pembrolizumab-induced Myopathy with Anti-striated Muscle Antibodies Successfully Treated by Plasma Exchange. (2023/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study of RVT-1401 in Myasthenia Gravis (MG) Patients (2023-12-20) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Exploring Accessible Beauty for Individuals With Upper Extremity Deficits (2023-12-06) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Prospective, Single-Center Investigation of the da Vinci SP® Surgical System in Anterior Mediastinal Disease (2023-10-31) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Univent Tube for Thoracoscopic Thymectomy in Myasthenic Patients (2023-10-26) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 Infection (2023-10-06) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study of Myasthenic Crisis in China (2023-09-21) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis (2023-09-05) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Safety and Tolerability Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness. (2023-07-14) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. An Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia Gravis (2023-06-27) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis (2023-06-27) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Pyridostigmine and Amifampridine for Myasthenia Gravis (2023-06-26) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis (2023-06-23) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Screening of Serum Exosomal miRNA as a Biomarker for Ocular Muscle Myasthenia Gravis (2023-06-05) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study of TAK-079 in People With Generalized Myasthenia Gravis (2023-06-02) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.